These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37029745)

  • 41. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.
    Meroni M; Dongiovanni P; Longo M; Carli F; Baselli G; Rametta R; Pelusi S; Badiali S; Maggioni M; Gaggini M; Fracanzani AL; Romeo S; Gatti S; Davidson NO; Gastaldelli A; Valenti L
    EBioMedicine; 2020 Feb; 52():102658. PubMed ID: 32058943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury.
    Varadharajan V; Ramachandiran L; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Guilshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
    bioRxiv; 2024 Jan; ():. PubMed ID: 37808828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers.
    Krawczyk M; Bantel H; Rau M; Schattenberg JM; Grünhage F; Pathil A; Demir M; Kluwe J; Boettler T; Weber SN; Geier A; Lammert F;
    J Hum Genet; 2018 May; 63(5):621-626. PubMed ID: 29483677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study.
    Xia M; Ma S; Huang Q; Zeng H; Ge J; Xu W; Wu Q; Wu L; Li X; Ma H; Chen L; Li Q; Aleteng Q; Hu Y; He W; Pan B; Lin H; Zheng Y; Wang S; Tang H; Gao X
    Aliment Pharmacol Ther; 2022 Mar; 55(6):705-721. PubMed ID: 35023183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LPIAT1/MBOAT7 contains a catalytic dyad transferring polyunsaturated fatty acids to lysophosphatidylinositol.
    Caddeo A; Hedfalk K; Romeo S; Pingitore P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158891. PubMed ID: 33513444
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Ismaiel A; Spinu M; Osan S; Leucuta DC; Popa SL; Chis BA; Farcas M; Popp RA; Olinic DM; Dumitrascu DL
    Med Pharm Rep; 2023 Jan; 96(1):41-51. PubMed ID: 36818318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans.
    Luukkonen PK; Zhou Y; Hyötyläinen T; Leivonen M; Arola J; Orho-Melander M; Orešič M; Yki-Järvinen H
    J Hepatol; 2016 Dec; 65(6):1263-1265. PubMed ID: 27520876
    [No Abstract]   [Full Text] [Related]  

  • 48. LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.
    Tanaka Y; Shimanaka Y; Caddeo A; Kubo T; Mao Y; Kubota T; Kubota N; Yamauchi T; Mancina RM; Baselli G; Luukkonen P; Pihlajamäki J; Yki-Järvinen H; Valenti L; Arai H; Romeo S; Kono N
    Gut; 2021 Jan; 70(1):180-193. PubMed ID: 32253259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
    Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
    Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Kalinowski P; Smyk W; Nowosad M; Paluszkiewicz R; Michałowski Ł; Ziarkiewicz-Wróblewska B; Weber SN; Milkiewicz P; Lammert F; Zieniewicz K; Krawczyk M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of host genetics on liver microbiome composition in patients with NAFLD.
    Pirola CJ; Salatino A; Quintanilla MF; Castaño GO; Garaycoechea M; Sookoian S
    EBioMedicine; 2022 Feb; 76():103858. PubMed ID: 35092912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review.
    Dwi Astarini F; Ratnasari N; Wasityastuti W
    Iran Biomed J; 2022 Jul; 26(4):252-68. PubMed ID: 36000237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of
    Di Sessa A; Umano GR; Cirillo G; Passaro AP; Verde V; Cozzolino D; Guarino S; Marzuillo P; Miraglia Del Giudice E
    World J Gastroenterol; 2020 Sep; 26(36):5474-5483. PubMed ID: 33024398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
    Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
    Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children.
    Di Costanzo A; Pacifico L; D'Erasmo L; Polito L; Martino MD; Perla FM; Iezzi L; Chiesa C; Arca M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505904
    [No Abstract]   [Full Text] [Related]  

  • 57. 13C-METHACETIN BREATHE TEST IN EARLY DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE.
    Sklyarova HE
    Wiad Lek; 2021; 74(3 cz 1):487-491. PubMed ID: 33813455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
    Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
    Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.
    Dongiovanni P; Paolini E; Corsini A; Sirtori CR; Ruscica M
    Eur J Clin Invest; 2021 Jul; 51(7):e13519. PubMed ID: 33583033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.
    Raja AM; Ciociola E; Ahmad IN; Dar FS; Naqvi SMS; Moaeen-Ud-Din M; Kaukab Raja G; Romeo S; Mancina RM
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.